Aztreonam lysine for inhalation solution in cystic fibrosis: profile report.

Suppr

超能文献

作者信息

Plosker Greg L

机构信息

Adis, a Wolters Kluwer Business, 41 Centorian Drive, Mairangi Bay, Auckland, New Zealand.

出版信息

Paediatr Drugs. 2011 Apr 1;13(2):129-31. doi: 10.2165/11206940-000000000-00000.

DOI:10.2165/11206940-000000000-00000

PMID:21351813

Abstract

摘要

相似文献

Aztreonam lysine for inhalation solution in cystic fibrosis: profile report.

Paediatr Drugs. 2011 Apr 1;13(2):129-31. doi: 10.2165/11206940-000000000-00000.

Aztreonam lysine for inhalation solution: in cystic fibrosis.

Drugs. 2010 Oct 1;70(14):1843-55. doi: 10.2165/10484070-000000000-00000.

Aztreonam for inhalation solution (Cayston) for cystic fibrosis.

Med Lett Drugs Ther. 2010 Aug 9;52(1344):63-4.

Aztreonam lysine: a novel inhalational antibiotic for cystic fibrosis.

Expert Rev Respir Med. 2010 Aug;4(4):435-44. doi: 10.1586/ers.10.48.

Lung clearance index to detect the efficacy of Aztreonam lysine inhalation in patients with cystic fibrosis and near normal spirometry - A single-centre feasibility study.

PLoS One. 2019 Sep 9;14(9):e0221673. doi: 10.1371/journal.pone.0221673. eCollection 2019.

Inhaled aztreonam.

Nat Rev Drug Discov. 2010 May;9(5):357-8. doi: 10.1038/nrd3170.

A treatment evaluator tool to monitor the real-world effectiveness of inhaled aztreonam lysine in cystic fibrosis.

J Cyst Fibros. 2017 Nov;16(6):695-701. doi: 10.1016/j.jcf.2017.02.006. Epub 2017 Apr 6.

Inhaled aztreonam lysine versus inhaled tobramycin in cystic fibrosis. An economic evaluation.

Ann Am Thorac Soc. 2015 Jul;12(7):1030-8. doi: 10.1513/AnnalsATS.201312-453OC.

Inhaled aztreonam lysine for cystic fibrosis pulmonary disease-related outcomes.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):1076-85. doi: 10.1345/aph.1Q653. Epub 2012 Jul 3.

Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.

Am J Respir Crit Care Med. 2008 Nov 1;178(9):921-8. doi: 10.1164/rccm.200712-1804OC. Epub 2008 Jul 24.

引用本文的文献

Aztreonam Lysine Inhalation Solution in Cystic Fibrosis.

Clin Med Insights Circ Respir Pulm Med. 2019 Apr 12;13:1179548419842822. doi: 10.1177/1179548419842822. eCollection 2019.

Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.

Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1231-52. doi: 10.1007/s10096-013-1876-y. Epub 2013 Apr 26.

本文引用的文献

Aztreonam lysine for inhalation solution: in cystic fibrosis.

Drugs. 2010 Oct 1;70(14):1843-55. doi: 10.2165/10484070-000000000-00000.

An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis.

Pediatr Pulmonol. 2010 Nov;45(11):1121-34. doi: 10.1002/ppul.21301.

Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis.

Chest. 2009 May;135(5):1223-1232. doi: 10.1378/chest.08-1421.

Aerosol antibiotics in cystic fibrosis.

Respir Care. 2009 May;54(5):658-70. doi: 10.4187/aarc0537.

Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.

Am J Respir Crit Care Med. 2008 Nov 1;178(9):921-8. doi: 10.1164/rccm.200712-1804OC. Epub 2008 Jul 24.

A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection.

Pediatr Pulmonol. 2008 Jan;43(1):47-58. doi: 10.1002/ppul.20736.

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

Am J Respir Crit Care Med. 2007 Nov 15;176(10):957-69. doi: 10.1164/rccm.200705-664OC. Epub 2007 Aug 29.

Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis.

Pediatr Pulmonol. 2006 Jul;41(7):656-65. doi: 10.1002/ppul.20429.

Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis.

Am J Respir Crit Care Med. 2006 Jul 15;174(2):208-12. doi: 10.1164/rccm.200509-1439OC. Epub 2006 Apr 20.

Inhaled antibiotics.

Pediatr Pulmonol Suppl. 2004;26:92-4. doi: 10.1002/ppul.70065.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Aztreonam lysine for inhalation solution in cystic fibrosis: profile report.

Paediatr Drugs. 2011 Apr 1;13(2):129-31. doi: 10.2165/11206940-000000000-00000.

Aztreonam lysine for inhalation solution: in cystic fibrosis.

Drugs. 2010 Oct 1;70(14):1843-55. doi: 10.2165/10484070-000000000-00000.

Aztreonam for inhalation solution (Cayston) for cystic fibrosis.

Med Lett Drugs Ther. 2010 Aug 9;52(1344):63-4.

Aztreonam lysine: a novel inhalational antibiotic for cystic fibrosis.

Expert Rev Respir Med. 2010 Aug;4(4):435-44. doi: 10.1586/ers.10.48.

Lung clearance index to detect the efficacy of Aztreonam lysine inhalation in patients with cystic fibrosis and near normal spirometry - A single-centre feasibility study.

PLoS One. 2019 Sep 9;14(9):e0221673. doi: 10.1371/journal.pone.0221673. eCollection 2019.

Inhaled aztreonam.

Nat Rev Drug Discov. 2010 May;9(5):357-8. doi: 10.1038/nrd3170.

A treatment evaluator tool to monitor the real-world effectiveness of inhaled aztreonam lysine in cystic fibrosis.

J Cyst Fibros. 2017 Nov;16(6):695-701. doi: 10.1016/j.jcf.2017.02.006. Epub 2017 Apr 6.

Inhaled aztreonam lysine versus inhaled tobramycin in cystic fibrosis. An economic evaluation.

Ann Am Thorac Soc. 2015 Jul;12(7):1030-8. doi: 10.1513/AnnalsATS.201312-453OC.

Inhaled aztreonam lysine for cystic fibrosis pulmonary disease-related outcomes.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):1076-85. doi: 10.1345/aph.1Q653. Epub 2012 Jul 3.

Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.

Am J Respir Crit Care Med. 2008 Nov 1;178(9):921-8. doi: 10.1164/rccm.200712-1804OC. Epub 2008 Jul 24.

引用本文的文献

Aztreonam Lysine Inhalation Solution in Cystic Fibrosis.

Clin Med Insights Circ Respir Pulm Med. 2019 Apr 12;13:1179548419842822. doi: 10.1177/1179548419842822. eCollection 2019.

Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.

Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1231-52. doi: 10.1007/s10096-013-1876-y. Epub 2013 Apr 26.

本文引用的文献

Aztreonam lysine for inhalation solution: in cystic fibrosis.

Drugs. 2010 Oct 1;70(14):1843-55. doi: 10.2165/10484070-000000000-00000.

An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis.

Pediatr Pulmonol. 2010 Nov;45(11):1121-34. doi: 10.1002/ppul.21301.

Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis.

Chest. 2009 May;135(5):1223-1232. doi: 10.1378/chest.08-1421.

Aerosol antibiotics in cystic fibrosis.

Respir Care. 2009 May;54(5):658-70. doi: 10.4187/aarc0537.

Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.

Am J Respir Crit Care Med. 2008 Nov 1;178(9):921-8. doi: 10.1164/rccm.200712-1804OC. Epub 2008 Jul 24.

A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection.

Pediatr Pulmonol. 2008 Jan;43(1):47-58. doi: 10.1002/ppul.20736.

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

Am J Respir Crit Care Med. 2007 Nov 15;176(10):957-69. doi: 10.1164/rccm.200705-664OC. Epub 2007 Aug 29.

Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis.

Pediatr Pulmonol. 2006 Jul;41(7):656-65. doi: 10.1002/ppul.20429.

Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis.

Am J Respir Crit Care Med. 2006 Jul 15;174(2):208-12. doi: 10.1164/rccm.200509-1439OC. Epub 2006 Apr 20.

Inhaled antibiotics.

Pediatr Pulmonol Suppl. 2004;26:92-4. doi: 10.1002/ppul.70065.